Search
for
Sort by
Research 181–210 of 362
- Primary cicatricial alopecias
- Cutaneous drug reactions
- Narrative Review of Skin and Pregnancy: Dermatologic Manifestations and Medication Management During Pregnancy
- Semaglutide and the Skin: An Overview of Current Evidence
- An Unusual Case of Elevated Testosterone: When Testosterone by Dialysis Saves the Day
- Tufted Hair Folliculitis Decalvans as a Clinical Diagnostic Sign
- Challenges in diagnosis and treatment of Cushing disease in a 12-year-old boy
- Secondary Adrenal Insufficiency : A Case Report
- EHRLICHIOSIS AND DEMODICOSIS IN BALI LOCAL DOG
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- A Severe Case of Folliculitis Decalvans
- Skin Disorders in Athletes: Professional and Recreational Sports
- Racial and Gender Influences on Skin Disease
- Benign Cutaneous Eruptions After Transplantation
- Steroid Hormones of Reproduction and Sexual Development
- Contents
- Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk
- American Academy of Dermatology
- In Silico and In Vitro Screening Constituents of Eclipta alba Leaf Extract to Reveal Antimicrobial Potential
- 43647 Treatment of Refractory Folliculitis Decalvans with the Topical JAK Inhibitor Tofacitinib
- Blue-gray discoloration of the skin after levofloxacin exposure in a 44-year-old man with pulmonary tuberculosis
- Finasteride
- Folliculitis decalvans: why is there no established treatment?
- Effective treatment of folliculitis decalvans using selected antimicrobial agents
- Long-term treatment with apremilast in hidradenitis suppurativa: A 2-year follow-up of initial responders
- Isonicotinic Acid Hydrazide Induced Anagen Effluvium and Associated Lichenoid Eruption
- Diagnostic delay, comorbid hidradenitis suppurativa and the prognostic value of bacterial culture in folliculitis decalvans: A cohort study
- An overview of current strategies and future prospects in drug repurposing in tuberculosis
- Refractory dissecting cellulitis of the scalp treated with risankizumab: 2 case reports
- Knowledge Mapping of Drug Repositioning’s Theme and Development